You are currently logged into
Cancer Health Directory - My Account or Log Out

Home
News
- News
- Newsfeed
- Science News
- Features
- Opinions
- Conferences
- Slideshows
- Cancer Health TV
- By Author
- RSS Links
Cancer Basics
Hot Topics
Magazine
Blogs
Community
About Us
- About Us
- Masthead
- Advertise
- Awards
- Contact Us
Facebook
Twitter

© 2023 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Twitter

Facebook

Tumblr

#Onureg

A Promising New Treatment for Some People with Acute Myeloid Leukemia

Ivosidenib (Tibsovo) plus chemotherapy may soon be an option for those with leukemia that has an IDH1 mutation.

Onureg

FDA Approves Onureg for Acute Myeloid Leukemia

The new drug improved overall survival for people who could not complete curative chemotherapy.

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.